Prion Diseases

  • Martin Beckerman
Chapter
Part of the Biological and Medical Physics, Biomedical Engineering book series (BIOMEDICAL)

Abstract

Recall from Chap.  1 that it took a visit to Papua New Guinea in the mid-1950s. At that time a rare but fatal disease, kuru, had broken out among the primitive Fore people. In response to what was clearly an unusual happening, the epidemiologist Carleton Gajdusek (1923–2008) traveled to the region at the invitation of the local medical officer, Vincent Zigas. Once he was in the region Gajdusek discovered that the disease was being transmitted by means of funerary cannibalistic feasts involving ingestion of brain tissue.

Keywords

Lipid Raft Prion Protein Prion Disease Bovine Spongiform Encephalopathy Chronic Wasting Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Bibliography

  1. Alper, T., Cramp, W. A., Haig, D. A., & Clarke, M. C. (1967). Does the agent of scrapie replicate without nucleic acid? Nature, 214, 764–766.CrossRefPubMedGoogle Scholar
  2. Alper, T., Haig, D. A., & Clarke, M. C. (1966). The exceptionally small size of the scrapie agent. Biochemical and Biophysical Research Communications, 22, 278–284.CrossRefPubMedGoogle Scholar
  3. Baron, G. S., Wehrly, K., Dorward, D. W., Chesebro, B., & Caughey, B. (2002). Conversion of raft-associated prion protein to the protease-resistant state requires insertion of PrP-res (PrPSc) into contiguous membranes. The EMBO Journal, 21, 1031–1040.PubMedCentralCrossRefPubMedGoogle Scholar
  4. Basler, K., Oesch, B., Scott, M., Westaway, D., Wälchli, M., Groth, D. F., et al. (1986). Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell, 46, 417–428.CrossRefPubMedGoogle Scholar
  5. Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., et al. (1996). Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature, 379, 339–343.CrossRefPubMedGoogle Scholar
  6. Castilla, J., Saá, P., Hetz, C., & Soto, C. (2005). In vitro generation of infectious scrapie prions. Cell, 121, 195–206.CrossRefPubMedGoogle Scholar
  7. Chesebro, B., Race, R., Wehrly, K., Nishio, J., Bloom, M., Lechner, D., et al. (1985). Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature, 315, 331–333.CrossRefPubMedGoogle Scholar
  8. Chesebro, B., Trifilo, M., Race, R., Meade-White, K., Teng, C., LaCasse, R., et al. (2005). Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science, 308, 1435–1439.CrossRefPubMedGoogle Scholar
  9. Deleault, N. R., Harris, B. T., Reese, J. R., & Supattapone, S. (2007). Formation of native prions from minimal components in vitro. Proceedings of the National Academy of Sciences of the United States of America, 104, 9741–9746.PubMedCentralCrossRefPubMedGoogle Scholar
  10. Deleault, N. R., Piro, J. R., Walsh, D. J., Wang, F., Ma, J., Geoghegan, J. C., & Supattapone, S. (2012). Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proceedings of the National Academy of Sciences of the United States of America, 109, 8546–8551.PubMedCentralCrossRefPubMedGoogle Scholar
  11. Gajdusek, D. C., Gibbs, C. J., Jr., & Alpers, M. (1966). Experimental transmission of a kuru-like syndrome to chimpanzees. Nature, 209, 794–796.CrossRefPubMedGoogle Scholar
  12. Gajdusek, D. C., & Zigas, V. (1957). Degenerative disease of the central nervous system in New Guinea: Epidemic occurrence of “kuru” in the native population. New England Journal of Medicine, 257, 974–978.CrossRefPubMedGoogle Scholar
  13. Gibbs, C. J., Jr., Gajdusek, D. C., Asher, D. M., Alpers, M. P., Beck, E., Daniel, P. M., et al. (1968). Creutzfeldt-Jakob disease (spongiform encephalopathy): Transmission to the chimpanzee. Science, 161, 388–389.CrossRefPubMedGoogle Scholar
  14. Griffith, J. S. (1967). Self-replication and scrapie. Nature, 215, 1043–1044.CrossRefPubMedGoogle Scholar
  15. Hadlow, W. J. (1959). Scrapie and kuru. Lancet, 2, 289–290.CrossRefGoogle Scholar
  16. Kocisko, D. A., Come, J. H., Priola, S. A., Chesebro, B., Raymond, G. J., Lansbury, P. T., et al. (1994). Cell-free formation of protease-resistant prion protein. Nature, 370, 471–474.CrossRefPubMedGoogle Scholar
  17. Mallucci, G., Dickinson, A., Linehan, J., Klöhn, P. C., Brandner, S., & Collinge, J. (2003). Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science, 302, 871–874.CrossRefPubMedGoogle Scholar
  18. Makarava, N., Kovacs, G. G., Bocharova, O., Savtchenko, R., Alexeeva, I., Budka, H., et al. (2010). Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathologica, 119, 177–187.PubMedCentralCrossRefPubMedGoogle Scholar
  19. Oesch, B., Westaway, D., Wälchli, M., McKinley, M. P., Kent, B. H., Aebersold, R., et al. (1985). A cellular gene encoding scrapie PrP 27–30 proteins. Cell, 40, 735–746.CrossRefPubMedGoogle Scholar
  20. Pan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., et al. (1993). Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proceedings of the National Academy of Sciences of the United States of America, 90, 10962–10966.PubMedCentralCrossRefPubMedGoogle Scholar
  21. Prusiner, S. B. (1982). Novel proteinaceous infectious particles cause scrapie. Science, 216, 136–144.CrossRefPubMedGoogle Scholar
  22. Prusiner, S. B., McKinley, M. P., Bowman, K. A., Bolton, D. C., Bendheim, P. E., Groth, D. F., et al. (1983). Scrapie prions aggregate to form amyloid-like birefringent rods. Cell, 35, 349–358.CrossRefPubMedGoogle Scholar
  23. Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R., & Wüthrich, K. (1996). NMR structure of the mouse prion protein domain PrP(121–231). Nature, 382, 180–182.CrossRefPubMedGoogle Scholar
  24. Sandberg, M. K., Al-Doujaily, H., Sharps, B., Clarke, A. R., & Collinge, J. (2011). Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature, 470, 540–542.CrossRefPubMedGoogle Scholar
  25. Silveira, J. R., Raymond, G. J., Hughson, A. G., Race, R. E., Sim, V. L., Hayes, S. F., et al. (2005). The most infectious prion protein particles. Nature, 437, 257–261.PubMedCentralCrossRefPubMedGoogle Scholar
  26. Wong, C., Xiong, L. W., Horiuchi, M., Raymond, L., Wehrly, K., Chesebro, B., et al. (2001). Sulfated glycans and elevated temperature stimulate PrPSc-dependent cell-free formation of protease-resistant prion protein. The EMBO Journal, 20, 377–386.PubMedCentralCrossRefPubMedGoogle Scholar

Prion Passage from Gut to Brain

  1. Mabbott, N. A., & MacPherson, G. G. (2006). Prions and their lethal journey to the brain. Nature Reviews. Microbiology, 4, 201–211.CrossRefPubMedGoogle Scholar

Prion Diseases in Animals and Humans

  1. Bruce, M. E., Will, R. G., Ironside, J. W., McConnell, I., Drummond, D., Suttie, A., et al. (1997). Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature, 389, 498–501.CrossRefPubMedGoogle Scholar
  2. Castilla, J., Gonzalez-Romero, D., Saá, P., Morales, R., de Castro, J., & Soto, C. (2008). Crossing the species barrier by PrPSc replication in vitro generates unique infectious prions. Cell, 134, 757–765.PubMedCentralCrossRefPubMedGoogle Scholar
  3. Chesebro, B. (2003). Introduction to the transmissible spongiform encephalopathies or prion diseases. British Medical Bulletin, 66, 1–20.CrossRefPubMedGoogle Scholar
  4. Collins, S., McLean, C. A., & Masters, C. L. (2001). Gerstmann-Sträussler-Scheinker syndrome, fatal familial insomnia, and kuru: A review of three less common human transmissible spongiform encephalopathies. Journal of Clinical Neuroscience, 8, 387–397.CrossRefPubMedGoogle Scholar
  5. Hill, A. F., Desbruslais, M., Joiner, S., Sidle, K. C. L., Gowland, I., Collinge, J., et al. (1997). The same prion strain causes vCJD and BSE. Nature, 389, 448–450.CrossRefPubMedGoogle Scholar
  6. Johnson, C. J., Phillips, K. E., Schramm, P. T., McKenzie, D., Aiken, J. M., & Pedersen, J. A. (2006). Prions adhere to soil minerals and remain infectious. PLoS Pathogens, 2, e32.PubMedCentralCrossRefPubMedGoogle Scholar
  7. Miller, M. W., Williams, E. S., Hobbs, N. T., & Wolfe, L. L. (2004). Environmental sources of prion transmission in mule deer. Emerging Infectious Diseases, 10, 1003–1006.PubMedCentralCrossRefPubMedGoogle Scholar
  8. Raymond, G. J., Bossers, A., Raymond, L. D., O’Rourke, K. I., McHolland, L. E., Bryant, P. K. III, et al. (2000). Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease. The EMBO Journal, 19, 4425–4430.PubMedCentralCrossRefPubMedGoogle Scholar
  9. Tamgüney, G., Miller, M. W., Wolfe, L. L., Sirochman, T. M., Glidden, D. V., Palmer, C., et al. (2009). Asymptomatic deer excrete infectious prions in feces. Nature, 461, 529–532.PubMedCentralCrossRefPubMedGoogle Scholar
  10. Vanik, D. L., Surewicz, K. A., & Surewicz, W. K. (2004). Molecular basis of barriers for interspecies transmissibility of mammalian prions. Molecular Cell, 14, 139–145.CrossRefPubMedGoogle Scholar
  11. Wadsworth, J. D. F., Hill, A., Beck, J. A., & Collinge, J. (2003). Molecular and clinical classification of human prion diseases. British Medical Bulletin, 66, 241–254.CrossRefPubMedGoogle Scholar

Prion Strains

  1. Beassen, R. A., Kocisko, D. A., Raymond, G. J., Nandan, S., Lansbury, P. T., & Caughey, B. (1995). Non-genetic propagation of strain-specific properties of scrapie prion. Nature, 375, 698–700.CrossRefGoogle Scholar
  2. Bessen, R. A., & Marsh, R. F. (1994). Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. Journal of General Virology, 68, 7859–7868.Google Scholar
  3. Collinge, J., & Clarke, A. R. (2007). A general model of prion strains and their pathogenicity. Science, 318, 930–936.CrossRefPubMedGoogle Scholar
  4. Jones, E. M., & Surewicz, W. K. (2005). Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell, 121, 163–172.CrossRefGoogle Scholar
  5. Legname, G., Baskakov, I. V., Nguyen, H. O. B., Riesner, D., Cohen, F. E., DeArmond, S. J., et al. (2004). Synthetic mammalian prions. Science, 305, 673–676.CrossRefPubMedGoogle Scholar
  6. Saborio, G. P., Permanne, B., & Soto, C. (2001). Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature, 411, 810–813.CrossRefPubMedGoogle Scholar
  7. Safar, J., Wille, H., Itri, V., Groth, D., Serban, H., Torchia, M., et al. (1998). Eight prion strains have PrP molecules with different conformations. Nature Medicine, 4, 1157–1165.CrossRefPubMedGoogle Scholar
  8. Tanaka, M., Chien, P., Naber, N., Cooke, R., & Weissman, J. S. (2004). Conformational variations in an infectious protein determine prion strain differences. Nature, 428, 323–328.CrossRefPubMedGoogle Scholar
  9. Telling, G. C., Parchi, P., DeArmond, S. J., Cortelli, P., Montagna, P., Gabizon, R., et al. (1996). Evidence for the conformation of the pathogenic isoform of the prion protein enciphering and propagating prion diversity. Science, 274, 2079–2082.CrossRefPubMedGoogle Scholar
  10. Toyama, B. H., Kelly, M. J. S., Gross, J. D., & Weissman, J. S. (2007). The structural basis of yeast prion strain variants. Nature, 449, 233–237.CrossRefPubMedGoogle Scholar

Prion Biogenesis, Structure and Function

  1. Bremer, J., Baumann, F., Tiberi, C., Wessig, C., Fischer, H., Schwarz, P., et al. (2010). Axonal prion protein is required for peripheral myelin maintenance. Nature Neuroscience, 13, 310–318.CrossRefPubMedGoogle Scholar
  2. Collinge, J. (1994). Prion protein is necessary for normal synaptic function. Nature, 370, 295–297.CrossRefPubMedGoogle Scholar
  3. Khosravani, H., Zhang, Y., Tsutsui, S., Hameed, S., Altier, C., Hamid, J., et al. (2008). Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. Journal of Cell Biology, 181, 551–565.PubMedCentralCrossRefPubMedGoogle Scholar
  4. Le Pichon, C. E., Valley, M. T., Polymenidou, M., Chesler, A. T., Sagdullaev, B. T., Aguzzi, A., et al. (2009). Olfactory behavior and physiology are disrupted in prion protein knockout mice. Nature Neuroscience, 12, 60–69.PubMedCentralCrossRefPubMedGoogle Scholar
  5. Málaga-Trillo, E., Solis, G. P., Schrock, Y., Geiss, C., Luncz, L., Thomanetz, V., et al. (2009). Regulation of embryonic cell adhesion by the prion protein. PLoS Biology, 7, e1000055.PubMedCentralCrossRefGoogle Scholar
  6. Mouillet-Richard, S., Ermonval, M., Chebassier, C., Laplanche, J. L., Lehrmann, S., Launay, J. M., et al. (2000). Signal transduction through prion protein. Science, 289, 1925–1928.CrossRefPubMedGoogle Scholar
  7. Santuccione, A., Sytnyk, V., Leshchynsʹka, I., & Schachner, M. (2005). Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. Journal of Cell Biology, 169, 341–354.PubMedCentralCrossRefPubMedGoogle Scholar
  8. Stahl, N., Baldwin, M. A., Teplow, D. B., Hood, L., Gibson, B. W., Burlingame, A. L., et al. (1993). Structural studies of the scrapie prion protein using mass spectroscopy and amino acid sequencing. Biochemistry, 32, 1991–2002.CrossRefPubMedGoogle Scholar
  9. Taylor, D. R., & Hooper, N. M. (2006). The prion protein and lipid rafts. Molecular Membrane Biology, 23, 89–99.CrossRefPubMedGoogle Scholar

Prion Toxicity

  1. Hetz, C., Russelakis-Carneiro, M., Maundrell, K., Castilla, J., & Soto, C. (2003). Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. The EMBO Journal, 22, 5435–5445.PubMedCentralCrossRefPubMedGoogle Scholar
  2. Kristiansen, M., Deriziotis, P., Dimcheff, D. E., Jachson, G. S., Ovaa, H., Naumann, H., et al. (2007). Disease-associated prion protein oligomers inhibit the 26S proteasome. Molecular Cell, 26, 175–188.CrossRefPubMedGoogle Scholar
  3. Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009). Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature, 457, 1128–1132.PubMedCentralCrossRefPubMedGoogle Scholar
  4. Moreno, J. A., Radford, H., Peretti, D., Steinert, J. R., Verity, N., Martin, M. G., et al. (2012). Sustained translational repression by eIF2α-P mediates prion neurodegeneration. Nature, 485, 507–511.PubMedCentralPubMedGoogle Scholar
  5. Rane, N. S., Kang, S. W., Chakrabarti, O., Feigenbaum, L., & Hedge, R. S. (2008). Reduced translocation of nascent prion protein during ER stress contributes to neurodegeneration. Developmental Cell, 15, 359–370.PubMedCentralCrossRefPubMedGoogle Scholar
  6. Resenberger, U. K., Harmeier, A., Woerner, A. C., Goodman, J. L., Müller, V., Krichnan, R., et al. (2011). The cellular prion protein mediates neurotoxic signaling of β-sheet-rich conformers independent of prion replication. The EMBO Journal, 30, 2057–2070.PubMedCentralCrossRefPubMedGoogle Scholar
  7. Sonati, T., Reimann, R. R., Falsig, J., Baral, P. K., O’Connor, T., Hornemann, S., et al. (2013). The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature, 501, 102–106.CrossRefPubMedGoogle Scholar
  8. Um, J. W., Nygaard, H. B., Heiss, J. K., Kostylev, M. A., Stagi, M., Vortmeyer, A., et al. (2012). Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nature Neuroscience, 15, 1227–1235.PubMedCentralCrossRefPubMedGoogle Scholar

Structure of the Prion Amyloid Fibrils

  1. Cobb, N. J., Sönnichsen, F. D., Mchaourab, H., & Surewicz, W. K. (2007). Molecular architecture of human prion protein amyloid: A parallel, in-register β-structure. Proceedings of the National Academy of Sciences of the United States of America, 104, 18946.PubMedCentralCrossRefPubMedGoogle Scholar
  2. DeMarco, M. L., & Daggett, V. (2004). From conversion to aggregation: Protofibril formation of the prion protein. Proceedings of the National Academy of Sciences of the United States of America, 101, 2293–2298.PubMedCentralCrossRefPubMedGoogle Scholar
  3. Govaerts, C., Wille, H., Prusiner, S. B., & Cohen, F. E. (2004). Evidence for assembly of prions with left-handed β-helices into trimers. Proceedings of the National Academy of Sciences of the United States of America, 101, 8342–8347.PubMedCentralCrossRefPubMedGoogle Scholar
  4. Krishnan, R., & Lindquist, S. L. (2005). Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature, 435, 765–772.PubMedCentralCrossRefPubMedGoogle Scholar
  5. Shewmaker, F., Wichner, R. B., & Tycko, R. (2006). Amyloid of the prion domain of Sup35p has an in-register parallel β-sheet structure. Proceedings of the National Academy of Sciences of the United States of America, 103, 19754–19759.PubMedCentralCrossRefPubMedGoogle Scholar
  6. Wickner, R. B., Dyda, F., & Tycko, R. (2008). Amyloid of Rnq1p, the basis of the [PIN+] prion, has a parallel in-register β-sheet structure. Proceedings of the National Academy of Sciences of the United States of America, 105, 2403–2408.PubMedCentralCrossRefPubMedGoogle Scholar

Fungal Prions

  1. Chernoff, Y. O., Lindquist, S. L., Ono, B., Inge-Vechtomov, S. G., & Liebman, S. W. (1995). Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science, 268, 880–884.CrossRefPubMedGoogle Scholar
  2. Halfmann, R., Jarosz, D. F., Jones, S. K., Chang, A., Lancaster, A. K., & Lindquist, S. (2012). Prions are a common mechanism for phenotypic inheritance in wild yeasts. Nature, 482, 363–368.PubMedCentralCrossRefPubMedGoogle Scholar
  3. Liebman, S. W., & Chernoff, Y. O. (2012). Prions in yeast. Genetics, 191, 1041–1072.PubMedCentralCrossRefPubMedGoogle Scholar
  4. Mukhopadhyay, S., Krishnan, R., Lemke, E. A., Lindquist, S., & Deniz, A. A. (2007). A natively unfolded yeast prion monomer adopts an ensemble of collapsed and rapidly fluctuating structures. Proceedings of the National Academy of Sciences of the United States of America, 104, 2649–2654.PubMedCentralCrossRefPubMedGoogle Scholar
  5. Serio, T. R. (2000). Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science, 289, 1317–1321.CrossRefPubMedGoogle Scholar
  6. Shorter, J., & Lindquist, S. (2004). Hsp 104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science, 304, 1793–1797.CrossRefPubMedGoogle Scholar
  7. True, H. L., Berlin, I., & Lindquist, S. L. (2004). Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits. Nature, 431, 184–187.CrossRefPubMedGoogle Scholar
  8. Tuite, M. F., & Serio, T. R. (2010). The prion hypothesis: From biological anomaly to basic regulatory mechanism. Nature Reviews. Molecular Cell Biology, 11, 823–833.PubMedCentralCrossRefPubMedGoogle Scholar
  9. Tyedmers, J., Madariaga, M. L., & Lindquist, S. (2008). Prion switching in response to environmental stress. PLoS Biology, 6, e294.PubMedCentralCrossRefPubMedGoogle Scholar
  10. Wickner, R. B. (1994). [URE3] is an altered URE2 protein: Evidence for a prion analog in Saccharomyces cerevisiae. Science, 264, 566–569.CrossRefPubMedGoogle Scholar

Beneficial Prions in Higher Organisms

  1. Hou, F., Sun, L., Zheng, H., Skaug, B., Jiang, Q. X., & Chen, Z. J. (2011). MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell, 146, 448–461.PubMedCentralCrossRefPubMedGoogle Scholar
  2. Si, K., Choi, Y. B., White-Grindley, E., Majumdar, A., & Kandel, E. R. (2010). Aplysia CPEB can form prion-like multimers in sensory neurons that contribute to long-term facilitation. Cell, 140, 421–435.CrossRefPubMedGoogle Scholar
  3. Si, K., Giustetto, M., Etkin, A., Hsu, R., Janisiewicz, A. M., Miniaci, M. C., et al. (2003). A neuronal isoform of CPEB regulates local protein synthesis and stabilizes synapse-specific long-term facilitation in Aplysia. Cell, 115, 893–904.CrossRefPubMedGoogle Scholar

Cell-to-Cell Spread

  1. Braak, H., & Braak, E. (1991). Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica, 82, 239–259.CrossRefPubMedGoogle Scholar
  2. Braak, H., del Tredici, K., Rüb, U., de Vos, R. A., Jansen Steur, E. N., & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging, 24, 197–211.CrossRefPubMedGoogle Scholar
  3. Fevrier, B., Vilette, D., Archer, F., Loew, D., Faigle, W., Vidal, M., et al. (2004). Cells release prions in association with exosomes. Proceedings of the National Academy of Sciences of the United States of America, 101, 9683–9688.PubMedCentralCrossRefPubMedGoogle Scholar
  4. Gousset, K., Schiff, E., Langevin, C., Marijanovic, Z., Caputo, A., Browman, D. T., et al. (2009). Prions hijack tunneling nanotubes for intercellular spread. Nature Cell Biology, 11, 328–336.CrossRefPubMedGoogle Scholar
  5. Lundmark, K., Westermark, G. T., Nyström, S., Murphy, C. L., Solomon, A., & Westermark, P. (2002). Transmissibility of systemic amyloidosis by a prion-like mechanism. Proceedings of the National Academy of Sciences of the United States of America, 99, 6979–6984.PubMedCentralCrossRefPubMedGoogle Scholar
  6. Rustom, A., Saffrich, R., Markovic, I., Walther, P., & Gerdes, H. H. (2004). Nanotubular highways for intercellular organelle transport. Science, 303, 1007–1010.CrossRefPubMedGoogle Scholar
  7. Simons, M., & Raposo, G. (2009). Exosomes—Vesicular carriers for intercellular communication. Current Opinion in Cell Biology, 21, 575–581.CrossRefPubMedGoogle Scholar
  8. Théry, C., Ostrowski, M., & Segura, E. (2009). Membrane vesicles as conveyors of immune responses. Nature Reviews. Immunology, 9, 581–593.CrossRefPubMedGoogle Scholar

Lipid Membranes

  1. Karnovsky, M. J., Kleinfeld, A. M., Hoover, R. L., & Klausner, R. D. (1982). The concept of lipid domains in membranes. The Journal of Cell Biology, 94, 1–6.CrossRefPubMedGoogle Scholar
  2. Simons, K., & Ikonen, E. (1997). Functional rafts in cell membranes. Nature, 387, 569–572.CrossRefPubMedGoogle Scholar
  3. Simons, K., & van Meer, G. (1988). Lipid sorting in epithelial cells. Biochemistry, 27, 6197–6202.CrossRefPubMedGoogle Scholar
  4. Singer, S. J., & Nicolson, G. L. (1972). The fluid mosaic model of the structure of cell membranes. Science, 175, 720–731.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Martin Beckerman
    • 1
  1. 1.AshevilleUSA

Personalised recommendations